Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/63624Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Aycik, Fatma Banu | - |
| dc.contributor.author | Ayyildiz, Mustafa | - |
| dc.contributor.author | Agar, Erdal | - |
| dc.date.accessioned | 2024-03-27T05:57:13Z | - |
| dc.date.available | 2024-03-27T05:57:13Z | - |
| dc.date.issued | 2024-04 | - |
| dc.identifier.issn | 0975-1009 (Online); 0019-5189 (Print) | - |
| dc.identifier.uri | http://nopr.niscpr.res.in/handle/123456789/63624 | - |
| dc.description | 238-244 | en_US |
| dc.description.abstract | Epilepsy is a widespread neurological disorder. Many neurotransmitters, neuropeptides and neuromodulators have a significant role in the epileptic activity. Apelin-13 and cannabinoid CB1 receptor agonist and antagonist have an effect in the penicillin model of epilepsy. The relationship between apelin and epilepsy, and the apelin-cannabinoid relationship in epilepsy is still not well understood. Thus, this study focuses on the relationship between apelin-13 and CB1 receptor in experimental model of epilepsy. Penicillin injection was given intracortically (i.c.) for the development of epileptic seizures. Ninety-one male Wistar rats were divided into 13 groups. CB1 receptor agonist ACEA (7.5 μg, intracerebroventricularly, icv) and antagonist AM-251 (0.25 μg and 0.125 μg, icv) were administered to three different groups, two different doses of apelin-13 (5 μg and 15 μg, icv) were applied and the interactions between these five groups of substances were evaluated. Both apelin-13 (15 μg) and AM-251 (0.25 μg) raised the spike frequency of epileptiform activity separately. Application of apelin-13 + AM-251 also increased the spike frequency of epileptiform activity beginning in the 30 min after apelin-13 application. When the non-effective dose of AM-251 and the effective dose of apelin-13 were administered together, epileptic activity increased in the 20 min. ACEA reduced the epileptiform activity starting in the 50th min. apelin-13 and ACEA administration in effective doses decreased epileptiform activity. The non-effective doses of AM-251, apelin-13 and effective dose of ACEA decreased the epileptiform activity in the 50 min. Application of non-effective doses of apelin and AM-251 together does not induce any additional proconvulsant activity, and CB1 receptor agonist, ACEA reversed the proconvulsant activity of apelin-13. These results suggest that they utilize different receptors to begin their own effects by increasing intracellular Ca2+ in epilepsy. Considering that apelin-13 is an endogenous substance known for its neuroprotective properties, the proconvulsant effect of apelin-13 in the presented study is remarkable. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | NIScPR-CSIR, India | en_US |
| dc.source | IJEB Vol.62(04) [April 2024] | en_US |
| dc.subject | Brain electrocorticograhy | en_US |
| dc.subject | Cannabinoid CB1 receptor agonists | en_US |
| dc.subject | Epilepsy | en_US |
| dc.subject | Neuromodulators | en_US |
| dc.title | Role of cannabinoid CB1 receptors in the proconvulsant effect of Apelin-13 on penicillin-induced epileptiform activity | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | https://doi.org/10.56042/ijeb.v62i04.655 | en_US |
| Appears in Collections: | IJEB Vol.62(04) [April 2024] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB Vol. 62 (04) 238-244.pdf | 944.06 kB | Adobe PDF | View/Open | |
| IJEB Vol. 62 (04) 238-244 Suppl.pdf | 390.22 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.